Events

Q&A session MSCA Staff Exchanges call 2026
MAR
Tue
03
15:00 - 17:00

This was 1 month ago

Location

Online

Programmes
MSCA

The Research Executive Agency (REA) is organising a Questions & Answer session on the MSCA Staff exchanges call 2026.

MSCA Staff Exchanges promote innovative international, inter-sectoral and interdisciplinary collaboration in research and innovation by enabling staff exchanges and the sharing of knowledge across all stages of the innovation chain. The objective is to support joint research and innovation projects through staff exchanges within partnerships involving universities, research infrastructures, businesses, and other socio-economic actors in Europe and beyond. These collaborations aim to build interdisciplinary, inter-sectoral (academic and non-academic) and international (EU Member States/Associated Countries and non-associated third countries) partnerships, while enabling participating staff (researchers at any career stage, as well as administrative, managerial, and technical personnel supporting the project’s R&I activities) to acquire new skills and competences.

A pre-recorded info session explains the key features of Staff Exchanges and the application process. The topics that are presented are:

  • Introduction and policy context 
  • 2026 Call and novelties 
  • Evaluation process 
  • Proposal submission 
  • Tips for a good proposal 
  • Open Science 
  • Ethics 
  • Conclusion and Q&A 

If after watching the info session the applicants still have questions they can be submitted via Slido and connect to the live Questions & Answers (Q&A) session. Link to pre-recorded info session (YouTube) and link to connect to Q&A session.

All the information related to the Q&A session on the MSCA Staff Exchanges call 2026 can be found in the announcement on the MSCA website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.